Anaplasma phagocytophilum and Ehrlichia chaffeensis: Subversive manipulators of host cells

Nature Reviews Microbiology

Volumn 8, Issue 5, 2010, Pages 328-339

  Rikihisa, Yasuko ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 FUCOSYLTRANSFERASE; BACTERIAL PROTEIN; DOXYCYCLINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN F; OUTER SURFACE PROTEIN A; P SELECTIN GLYCOPROTEIN LIGAND 1; PEPTIDOGLYCAN; PROTEIN P28; PROTEIN P44; RNA 16S; X LINKED INHIBITOR OF APOPTOSIS;

ADAPTATION; ANAPLASMA PHAGOCYTOPHILUM; APOPTOSIS; AUTOPHAGY; BACTERIAL GENOME; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL TRANSMISSION; BIOSYNTHESIS; CELL DIVISION; CELL MATURATION; CHLAMYDIA TRACHOMATIS; CHOLESTEROL TRANSPORT; COXIELLA BURNETII; EHRLICHIA CANIS; EHRLICHIA CHAFFEENSIS; EHRLICHIA RUMINANTIUM; ENDOCYTOSIS; ESCHERICHIA COLI; EUKARYOTIC CELL; GENE DELETION; GENE LOCUS; GENE SEQUENCE; HOST CELL; IXODES SCAPULARIS; LIFE CYCLE; NEORICKETTSIA SENNETSU; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RICKETTSIA PROWAZEKII; SEROCONVERSION; TICK; TYPE IV SECRETION SYSTEM; UPREGULATION;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; APOPTOSIS; AUTOPHAGY; BACTERIAL PROTEINS; CHOLESTEROL; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; GENOME, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; PHYLOGENY;

ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EUKARYOTA; IXODIDA; MAMMALIA;

EID: 77951097433     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2318     Document Type: Review

References (150)

1. Theiler, A. Anaplasma marginale (gen. and spec. nov.) The marginal points in the blood of cattle suffering from specific disease. Transvaal S. Afr. Rep.Vet. Bacteriol. Dept. Agr. 1908-1909, 7-64 (1910).
2. Thomas, R. J., Dumler, J. S. & Carlyon, J. A. Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev. Anti Infect. Ther. 7, 709-722 (2009).
3. Paddock, C. D. & Childs, J. E. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin. Microbiol. Rev. 16, 37-64 (2003).
4. Bakken, J. S. & Dumler, S. Human granulocytic anaplasmosis. Infect. Dis. Clin. North Am. 22, 433-448 (2008).
5. Olano, J. P. & Walker, D. H. Human ehrlichioses. Med. Clin. North Am. 86, 375-392 (2002).
6. Gardner, S. L., Holman, R. C., Krebs, J. W., Berkelman, R. & Childs, J. E. National surveillance for the human ehrlichioses in the United States, 1997-2001, and proposed methods for evaluation of data quality. Ann. N.Y. Acad. Sci. 990, 80-89 (2003).
7. Newton, P. N. et al. Sennetsu neorickettsiosis: a probable fish-borne cause of fever rediscovered in Laos. Am. J. Trop. Med. Hyg. 81, 190-194 (2009).
8. Perez, M., Bodor, M., Zhang, C., Xiong, Q. & Rikihisa, Y. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann. N.Y. Acad. Sci. 107 8, 110-117 (2006).
9. Perez, M., Rikihisa, Y. & Wen, B. Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J. Clin. Microbiol. 34, 2133-2139 (1996).
10. Allsopp, M. T., Louw, M. & Meyer, E. C. Ehrlichia ruminantium: an emerging human pathogen? Ann. N.Y. Acad. Sci. 1063, 358-360 (2005).
11. Rikihisa, Y. Ehrlichia subversion of host innate responses. Curr. Opin. Microbiol. 9, 95-101 (2006).
12. Rikihisa, Y. Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum. Vet. Parasitol. 167, 155-166 (2010).
13. Winslow, G. M. & Bitsaktsis, C. Immunity to the ehrlichiae: new tools and recent developments. Curr. Opin. Infect. Dis. 18, 217-221 (2005).
14. Carlyon, J. A. & Fikrig, E. Mechanisms of evasion of neutrophil killing by Anaplasma phagocytophilum. Curr. Opin. Hematol. 13, 28-33 (2006).
15. Rikihisa, Y. in Intracellular Niches of Microbes. A Pathogen's Guide Through the Host Cell (eds Schaible, U. & Haas, A.)
16. Ewing, S. A. et al. Experimental transmission of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) among white-tailed deer by Amblyomma americanum (Acari: Ixodidae). J. Med. Entomol. 32, 368-374 (1995).
17. Telford, S. R. 3rd et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl Acad. Sci. USA 93, 6209-6214 (1996).
18. Gieg, J., Rikihisa, Y. & Wellman, M. Diagnosis of Ehrlichia ewingii infection by PCR in a puppy from Ohio. Vet. Clin. Pathol. 38, 406-410 (2009).
19. Buller, R. S. et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N. Engl. J. Med. 341, 148-155 (1999).
20. Steiert, J. G. & Gilfoy, F. Infection rates of Amblyomma americanum and Dermacentor variabilis by Ehrlichia chaffeensis and Ehrlichia ewingii in southwest Missouri. Vector Borne Zoonotic Dis. 2, 53-60 (2002).
21. Anziani, O. S., Ewing, S. A. & Barker, R. W. Experimental transmission of a granulocytic form of the tribe Ehrlichieae by Dermacentor variabilis and Amblyomma americanum to dogs. Am. J. Vet. Res. 51, 929-931 (1990).
22. Zhang, L. et al. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 300, 2263-2270 (2008).
23. Krause, P. J. & Wormser, G. P. Nosocomial transmission of human granulocytic anaplasmosis? JAMA 300, 2308-2309 (2008).
24. Lin, M. & Rikihisa, Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun. 71, 5324-5331 (2003).
25. Herron, M. J. et al. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 288, 1653-1656 (2000).
26. Reneer, D. V. et al. Characterization of a sialic acid-and P-selectin glycoprotein ligand-1-independent adhesin activity in the granulocytotropic bacterium Anaplasma phagocytophilum. Cell. Microbiol. 8, 1972-1984 (2006).
27. Munderloh, U. G. et al. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet. Microbiol. 101, 53-64 (2004).
28. Carlyon, J. A. et al. Murine neutrophils require α1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102, 3387-3395 (2003).
29. Lin, M. & Rikihisa, Y. Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell. Microbiol. 5, 809-820 (2003).
30. Mott, J., Rikihisa, Y. & Tsunawaki, S. Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect. Immun. 70, 1359-1366 (2002).
31. Carlyon, J. A., Abdel-Latif, D., Pypaert, M., Lacy, P. & Fikrig, E. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect. Immun. 72, 4772-4783 (2004).
32. IJdo, J. & Mueller, A. C. Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome. Infect. Immun. 72, 5392-5401 (2004).
33. phox and inhibition of superoxide generation by Ehrlichia chaffeensis in human monocytes. Cell. Microbiol. 9, 861-874 (2007).
34. Webster, P., IJdo, J. W., Chicoine, L. M. & Fikrig, E. The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J. Clin. Invest. 101, 1932-1941 (1998).
35. Mott, J., Barnewall, R. E. & Rikihisa, Y. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67, 1368-1378 (1999).
36. Niu, H., Yamaguchi, M. & Rikihisa, Y. Subversion of cellular autophagy by Anaplasma phagocytophilum. Cell. Microbiol. 10, 593-605 (2008).
37. Dunning Hotopp, J. C. et al. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet. 2, e21 (2006).
38. Omsland, A. et al. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc. Natl Acad. Sci. USA 106, 4430-4434 (2009).
39. Andersson, S. G. et al. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396, 133-140 (1998).
40. Stephens, R. S. et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282, 754-759 (1998).
41. Seshadri, R. et al. Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc. Natl Acad. Sci. USA 100, 5455-5460 (2003).
42. Lin, M., Zhang, C., Gibson, K. & Rikihisa, Y. Analysis of complete genome sequence of Neorickettsia risticii: causative agent of Potomac horse fever. Nucleic Acid Res. 37, 6076-6079 (2009).
43. Foster, J. et al. The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol. 3, e121 (2005).
44. Wu, M. et al. Phylogenomics of the reproductive parasite Wolbachia pipientis wMel: a streamlined genome overrun by mobile genetic elements. PLoS Biol. 2, e69 (2004).
45. Brayton, K. A. et al. Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc. Natl Acad. Sci. USA 10 2, 844-849 (2005).
46. Collins, N. E. et al. The genome of the heartwater agent Ehrlichia ruminantium contains multiple tandem repeats of actively variable copy number. Proc. Natl Acad. Sci. USA 10 2, 838-843 (2005).
47. Mavromatis, K. et al. The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategies. J. Bacteriol. 188, 4015-4023 (2006).
48. Ogata, H. et al. Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 293, 2093-2098 (2001).
49. Felsheim, R. F. et al. Transformation of Anaplasma phagocytophilum. BMC Biotechnol. 6, 42 (2006). This article describes the first transformation of A. phagocytophilum with the Himar transposase system.
50. Ge, Y. & Rikihisa, Y. Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J. Bacteriol. 189, 7819-7828 (2007).
51. Ge, Y. & Rikihisa, Y. Surface-exposed proteins of Ehrlichia chaffeensis. Infect. Immun. 75, 3833-3841 (2007).
52. Unver, A. et al. Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. J. Clin. Microbiol. 39, 3982-3986 (2001).
53. Unver, A. et al. Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and-negative human sera by using native and recombinant E. chaffeensis and E. canis antigens. J. Clin. Microbiol. 37, 3888-3895 (1999).
54. Zhi, N. et al. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J. Clin. Microbiol. 36, 1666-1673 (1998).
55. Zhi, N., Rikihisa, Y., Kim, H. Y., Wormser, G. P. & Horowitz, H. W. Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J. Clin. Microbiol. 35, 2606-2611 (1997).
56. IJdo, J. W., Wu, C., Magnarelli, L. A. & Fikrig, E. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J. Clin. Microbiol. 37, 3540-3544 (1999).
57. Lin, Q., Rikihisa, Y., Ohashi, N. & Zhi, N. Mechanisms of variable p44 expression by Anaplasma phagocytophilum. Infect. Immun. 71, 5650-5661 (2003).
58. Lin, Q. et al. Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J. Clin. Microbiol. 40, 2981-2988 (2002).
59. Zhi, N., Ohashi, N. & Rikihisa, Y. Multiple p44 genes encoding major outer membrane proteins are expressed in the human granulocytic ehrlichiosis agent. J. Biol. Chem. 274, 17828-17836 (1999).
60. Barbet, A. F., Lundgren, A., Yi, J., Rurangirwa, F. R. & Palmer, G. H. Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics. Infect. Immun. 68, 6133-6138 (2000)
61. Barbet, A. F. et al. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect. Immun. 71, 1706-1718 (2003).
62. Lin, Q. & Rikihisa, Y. Establishment of cloned Anaplasma phagocytophilum and analysis of p44 gene conversion within an infected horse and infected SCID mice. Infect. Immun. 73, 5106-5114 (2005).
63. Lin, Q., Zhang, C. & Rikihisa, Y. Analysis of involvement of the RecF pathway in p44 recombination in Anaplasma phagocytophilum and in Escherichia coli by using a plasmid carrying the p44 expression and p44 donor loci. Infect. Immun. 74, 2052-2062 (2006)
64. Wang, X. et al. Rapid sequential changeover of expressed p44 genes during the acute phase of Anaplasma phagocytophilum infection in horses. Infect. Immun. 72, 6852-6859 (2004).
65. Granquist, E. G. et al. Variant-specific and diminishing immune responses towards the highly variable MSP2(P44) outer membrane protein of Anaplasma phagocytophilum during persistent infection in lambs. Vet. Immunol. Immunopathol. 133, 117-124 (2009).
66. Granquist, E. G., Stuen, S., Lundgren, A. M., Braten, M. & Barbet, A. F. Outer membrane protein sequence variation in lambs experimentally infected with Anaplasma phagocytophilum. Infect. Immun. 76, 120-126 (2008).
67. Ladbury, G. A. et al. Dynamic transmission of numerous Anaplasma phagocytophilum genotypes among lambs in an infected sheep flock in an area of anaplasmosis endemicity. J. Clin. Microbiol. 46, 1686-1691 (2008).
68. Sarkar, M. et al. Anaplasma phagocytophilum MSP2(P44)-18 predominates and is modified into multiple isoforms in human myeloid cells. Infect. Immun. 76, 2090-2098 (2008).
69. Troese, M. J. et al. Differential expression and glycosylation of Anaplasma phagocytophilum major surface protein 2 paralogs during cultivation in sialyl Lewis x-deficient host cells. Infect. Immun. 77, 1746-1756 (2009).
70. Scorpio, D. G., Caspersen, K., Ogata, H., Park, J. & Dumler, J. S. Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol. 4, 1 (2004).
71. Zhi, N. et al. Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Infect. Immun. 70, 1175-1184 (2002).
72. Felek, S., Telford, S. 3rd, Falco, R. C. & Rikihisa, Y. Sequence analysis of p44 homologs expressed by Anaplasma phagocytophilum in infected ticks feeding on naive hosts and in mice infected by tick attachment. Infect. Immun. 72, 659-666 (2004).
73. Barbet, A. F. et al. Structure of the expression site reveals global diversity in MSP2 (P44) variants in Anaplasma phagocytophilum. Infect. Immun. 74, 6429-6437 (2006).
74. Wang, X., Cheng, Z., Zhang, C., Kikuchi, T. & Rikihisa, Y. Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR. J. Bacteriol. 189, 8651-8659 (2007).
75. Wang, X., Kikuchi, T. & Rikihisa, Y. Proteomic identification of a novel Anaplasma phagocytophilum DNA binding protein that regulates a putative transcription factor. J. Bacteriol. 189, 4880-4886 (2007).
76. Nelson, C. M. et al. Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics 9, 364 (2008).
77. Ohashi, N., Rikihisa, Y. & Unver, A. Analysis of transcriptionally active gene clusters of major outer membrane protein multigene family in Ehrlichia canis and E. chaffeensis. Infect. Immun. 69, 2083-2091 (2001). (Pubitemid 32239672)
78. Zhang, C., Xiong, Q., Kikuchi, T. & Rikihisa, Y. Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay. Clin. Vaccine Immunol. 15, 402-411 (2008).
79. van Heerden, H., Collins, N. E., Brayton, K. A., Rademeyer, C. & Allsopp, B. A. Characterization of a major outer membrane protein multigene family in Ehrlichia ruminantium. Gene 330, 159-168 (2004).
80. Miura, K. & Rikihisa, Y. Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect. Immun. 75, 3604-3613 (2007).
81. Cheng, C., Paddock, C. D. & Reddy Ganta, R. Molecular heterogeneity of Ehrlichia chaffeensis
82. Isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome. Infect. Immun. 71, 187-195 (2003).
83. Long, S. W. et al. Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect. Immun. 70, 1824-1831 (2002).
84. Yu, X. J., McBride, J. W. & Walker, D. H. Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis. J. Clin. Microbiol. 37, 1137-1143 (1999).
85. Unver, A., Rikihisa, Y., Stich, R. W., Ohashi, N. & Felek, S. The omp-1 major outer membrane multigene family of Ehrlichia chaffeensis is differentially expressed in canine and tick hosts. Infect. Immun. 70, 4701-4704 (2002).
86. Zhang, J. Z., Guo, H., Winslow, G. M. & Yu, X. J. Expression of members of the 28-kilodalton major outer membrane protein family of Ehrlichia chaffeensis during persistent infection. Infect. Immun. 72, 4336-4343 (2004).
87. Singu, V., Liu, H., Cheng, C. & Ganta, R. R. Ehrlichia chaffeensis expresses macrophage-and tick cell-specific 28-kilodalton outer membrane proteins. Infect. Immun. 73, 79-87 (2005).
88. Unver, A. et al. Transcriptional analysis of p30 major outer membrane multigene family of Ehrlichia canis in dogs, ticks, and cell culture at different temperatures. Infect. Immun. 69, 6172-6178 (2001).
89. Kim, H. Y. & Rikihisa, Y. Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent. J. Clin. Microbiol. 36, 3278-3284 (1998).
90. Wang, X., Kikuchi, T. & Rikihisa, Y. Two monoclonal antibodies with defined epitopes of P44 major surface proteins neutralize Anaplasma phagocytophilum by distinct mechanisms. Infect. Immun. 74, 1873-1882 (2006).
91. Park, J., Choi, K. S. & Dumler, J. S. Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect. Immun. 71, 4018-4025 (2003). (Pubitemid 36753728)
92. Ohashi, N., Zhi, N., Zhang, Y. & Rikihisa, Y. Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family. Infect. Immun. 66, 132-139 (1998).
93. Li, J. S., Chu, F., Reilly, A. & Winslow, G. M. Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization. J. Immunol. 169, 1419-1425 (2002).
94. Winslow, G. M. et al. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect. Immun. 68, 2187-2195 (2000).
95. Kumagai, Y., Huang, H. & Rikihisa, Y. Expression and porin activity of P28 and OMP-1F during intracellular Ehrlichia chaffeensis development. J. Bacteriol. 190, 3597-3605 (2008).
96. Huang, H., Wang, X., Kikuchi, T., Kumagai, Y. & Rikihisa, Y. Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44. J. Bacteriol. 189, 1998-2006 (2007).
97. Gentle, I. E., Burri, L. & Lithgow, T. Molecular architecture and function of the Omp85 family of proteins. Mol. Microbiol. 58, 1216-1225 (2005).
98. Voulhoux, R., Bos, M. P., Geurtsen, J., Mols, M. & Tommassen, J. Role of a highly conserved bacterial protein in outer membrane protein assembly. Science 299, 262-265 (2003).
99. Popov, V. L., Yu, X. & Walker, D. H. The 120 kDa outer membrane protein of Ehrlichia chaffeensis: preferential expression on dense-core cells and gene expression in Escherichia coli associated with attachment and entry. Microb. Pathog. 28, 71-80 (2000).
100. Doyle, C. K., Nethery, K. A., Popov, V. L. & McBride, J. W. Differentially expressed and secreted major immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis elicit early antibody responses to epitopes on glycosylated tandem repeats. Infect. Immun. 74, 711-720 (2006).
101. Luo, T., Zhang, X., Wakeel, A., Popov, V. L. & McBride, J. W. A variable-length PCR target protein of Ehrlichia chaffeensis contains major species-specific antibody epitopes in acidic serine-rich tandem repeats. Infect. Immun. 76, 1572-1580 (2008).
102. McBride, J. W., Yu, X. J. & Walker, D. H. A conserved, transcriptionally active p28 multigene locus of Ehrlichia canis. Gene 254, 245-252 (2000).
103. Yu, X. J., McBride, J. W., Diaz, C. M. & Walker, D. H. Molecular cloning and characterization of the 120-kilodalton protein gene of Ehrlichia canis and application of the recombinant 120-kilodalton protein for serodiagnosis of canine ehrlichiosis. J. Clin. Microbiol. 38, 369-374 (2000).
104. McBride, J. W., Yu, X. J. & Walker, D. H. Glycosylation of homologous immunodominant proteins of Ehrlichia chaffeensis and Ehrlichia canis. Infect. Immun. 68, 13-18 (2000).
105. Luo, T., Zhang, X. & McBride, J. W. Major species-specific antibody epitopes of the Ehrlichia chaffeensis p120 and, E. canis p140 orthologs in surface-exposed tandem repeat regions. Clin. Vaccine Immunol. 16, 982-990 (2009).
106. Huang, H. et al. Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins. Infect. Immun. 76, 3405-3414 (2008).
107. Rikihisa, Y. The tribe Ehrlichieae and ehrlichial diseases. Clin. Microbiol. Rev. 4, 286-308 (1991).
108. Reichard, M. V. et al. Inoculation of white-tailed deer (Odocoileus virginianus) with Ap-V1 or NY-18 strains of Anaplasma phagocytophilum and microscopic demonstration of Ap-V1 In Ixodes scapularis adults that acquired infection from deer as nymphs. Vector Borne Zoonotic Dis. 9, 565-568 (2009).
109. Woldehiwet, Z. & Scott, G. R. Stages in the development of Cytoecetes phagocytophila, the causative agent of tick-borne fever. J. Comp. Pathol. 92, 469-474 (1982). (Pubitemid 13246722)
110. Popov, V. L., Chen, S. M., Feng, H. M. & Walker, D. H. Ultrastructural variation of cultured Ehrlichia chaffeensis. J. Med. Microbiol. 43, 411-421 (1995).
111. Munderloh, U. G. et al. Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J. Clin. Microbiol. 37, 2518-2524 (1999).
112. Troese, M. J. & Carlyon, J. A. Anaplasma phagocytophilum dense-cored organisms mediate cellular adherence through recognition of human P-selectin glycoprotein ligand 1. Infect. Immun. 77, 4018-4027 (2009).
113. Zhang, J. Z., Popov, V. L., Gao, S., Walker, D. H. & Yu, X. J. The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cell. Microbiol. 9, 610-618 (2007).
114. Ito, S. & Rikihisa, Y. inRickettsiae and Rickettsial Diseases (eds Burgdorfer, W. & Anacker, R. L.) 213-227 (Academic Press, New York, 1981).
115. Cheng, Z., Wang, X. & Rikihisa, Y. Regulation of type IV secretion apparatus genes during Ehrlichia chaffeensis intracellular development by a previously unidentified protein. J. Bacteriol. 190, 2096-2105 (2008).
116. Lai, T. H., Kumagai, Y., Hyodo, M., Hayakawa, Y. & Rikihisa, Y. The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic di-GMP in host cell infection. J. Bacteriol. 191, 693-700 (2009).
117. Niu, H., Rikihisa, Y., Yamaguchi, M. & Ohashi, N. Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway. Cell. Microbiol. 8, 523-534 (2006).
118. Heinzen, R. A. & Hackstadt, T. A developmental stage-specific histone H1 homolog of Coxiella burnetii. J. Bacteriol. 178, 5049-5052 (1996).
119. Hackstadt, T., Baehr, W. & Ying, Y. Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. Proc. Natl Acad. Sci. USA 88, 3937-3941 (1991).
120. Cheng, Z., Kumagai, Y., Lin, M., Zhang, C. & Rikihisa, Y. Intra-leukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel. Cell. Microbiol. 8, 1241-1252 (2006).
121. Kumagai, Y., Cheng, Z., Lin, M. & Rikihisa, Y. Biochemical activities of three pairs of Ehrlichia chaffeensis two-component regulatory system proteins involved in inhibition of lysosomal fusion. Infect. Immun. 74, 5014-5022 (2006).
122. Romling, U. Cyclic di-GMP (c-di-GMP) goes into host cells\c-di-GMP signaling in the obligate intracellular pathogen Anaplasma phagocytophilum. J. Bacteriol. 191, 683-686 (2009).
123. Alvarez-Marinez, C. E. & Christie, P. J. C. Biological diversities of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73, 775-808 (2009).
124. Rikihisa, Y. & Lin, M. Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins. Curr. Opin. Microbiol. 13, 59-66 (2010).
125. Bao, W. et al. Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles. J. Bacteriol. 191, 278-286 (2009).
126. Lin, M., den Dulk-Ras, A., Hooykaas, P. J. & Rikihisa, Y. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell. Microbiol. 9, 2644-2657 (2007)
127. IJdo, J., Carlson, A. C. & Kennedy, E. L. Anaplasma phagocytophilum AnkA is tyrosine-phosphorylated at EPIYA motifs and recruits SHP-1 during early infection. Cell. Microbiol. 9, 1284-1296 (2007).
128. Park, J., Kim, K. J., Choi, K. S., Grab, D. J. & Dumler, J. S. Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell. Microbiol. 6, 743-751 (2004).
129. Garcia-Garcia, J. C., Rennoll-Bankert, K. E., Pelly, S., Milstone, A. M. & Dumler, J. S. Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect. Immun. 77, 2385-2391 (2009).
130. Garcia-Garcia, J. C., Barat, N. C., Trembley, S. J. & Dumler, J. S. Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Path. 5, e1000488 (2009)
131. Zhu, B. et al. Nuclear translocated Ehrlichia chaffeensis ankyrin protein interacts with a specific adenine-rich motif of host promoter and intronic Alu elements. Infect. Immun. 77, 4243-4255 (2009).
132. Pan, X., Luhrmann, A., Satoh, A., Laskowski-Arce, M. A. & Roy., C. R. Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors. Science 320, 1651-1654 (2008).
133. Wakeel, A., Kuriakose, J. A. & McBride, J. W. An Ehrlichia chaffeensis tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle trafficking. Infect. Immun. 77, 1734-1745 (2009).
134. Yoshiie, K., Kim, H. Y., Mott, J. & Rikihisa, Y. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect. Immun. 68, 1125-1133 (2000). (Pubitemid 30108500)
135. Ge, Y., Yoshiie, K., Kuribayashi, F., Lin, M. & Rikihisa, Y. Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell. Microbiol. 7, 29-38 (2005).
136. Scaife, H., Woldehiwet, Z., Hart, C. A. & Edwards, S. W. Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect. Immun. 71, 1995-2001 (2003).
137. Borjesson, D. L. et al. Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J. Immunol. 174, 6364-6372 (2005).
138. Choi, K. S., Park, J. T. & Dumler, J. S. Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway. Infect. Immun. 73, 8209-8218 (2005).
139. Lee, H. C. & Goodman, J. L. Anaplasma phagocytophilum causes global induction of antiapoptosis in human neutrophils. Genomics 88, 496-503 (2006).
140. Ge, Y. & Rikihisa, Y. Anaplasma phagocytophilum delays spontaneous human neutrophil apoptosis by modulation of multiple apoptotic pathways. Cell. Microbiol. 8, 1406-1416 (2006).
141. Pedra, J. H., Sukumaran, B., Carlyon, J. A., Berliner, N. & Fikrig, E. Modulation of NB4 promyelocytic leukemic cell machinery by Anaplasma phagocytophilum. Genomics 86, 365-377 (2005).
142. Zhang, J. Z., Sinha, M., Luxon, B. A. & Yu, X. J. Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect. Immun. 72, 498-507 (2004).
143. Niu, H., Kozjak-Pavlovic, V., Rudel, T. & Rikihisa, Y. Anaplasma phagocytophilum Ats-1 is Imported into host cell mitochondria. PLoS Path. 6, e1000774 (2010).
144. Amano, A., Nakagawa, I. & Yoshimori, T. Autophagy in innate immunity against intracellular bacteria. J. Biochem. 140, 161-166 (2006).
145. Ling, Y. M. et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp.Med. 203, 2063-2071 (2006).
146. Schmid, D., Dengjel, J., Schoor, O., Stevanovic, S. & Munz, C. Autophagy in innate and adaptive immunity against intracellular pathogens. J. Mol. Med. 84, 194-202 (2006).
147. Xiong, Q., Lin, M. & Rikihisa, Y. Cholesterol-dependent Anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Path. 5, e1000329 (2009).
148. Berry, D. S. et al. Ehrlichial meningitis with cerebrospinal fluid morulae. Pediatr. Infect. Dis. J. 18, 552-555 (1999).
149. Dunn, B. E. et al. Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J. Clin. Microbiol. 30, 2207-2210 (1992).
150. Ratnasamy, N., Everett, E. D., Roland, W. E., McDonald, G. & Caldwell, C. W. Central nervous system manifestations of human ehrlichiosis. Clin. Infect. Dis. 23, 314-319 (1996).